Search Within

GDMT, Medicine

  1. "Stuart Lichtman"
Formats
  1. Journal Article (37)
  2. Meeting Abstract (30)
  3. Review (1)
Groups
  1. Department of Medicine (68)
  2. Gynecologic Medicine Service (68)
  3. Gynecology Disease Management Team (68)
  4. Solid Tumor Oncology Division (68)
  5. Hematologic Malignancies, Division of (20)
  6. Epidemiology and Biostatistics (16)

More Groups

People
  1. Stuart Lichtman (68)
  2. William Tew (59)
  3. Carol Aghajanian (15)
  4. Roisin O'Cearbhaill (14)
  5. Jason Konner (13)
  6. Qin Zhou (12)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2022 (4)
  4. 2021 (3)
  5. 2020 (2)
  6. 2019 (2)

More Years

Publications
  1. Journal of Clinical Oncology (37)
  2. Gynecologic Oncology (7)
  3. Journal of Geriatric Oncology (5)
  4. Cancer (3)
  5. Journal of the American Geriatrics Society (3)
  6. The Oncologist (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (39)
  2. Elsevier Inc. (13)
  3. Wiley Blackwell (6)
  4. Oxford University Press (3)
  5. American Association for Cancer Research (1)
  6. Harborside Press (1)

More Publishers

Results (68)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Germline landscape of ovarian cancer across age groups: Spotlight on elderly patients
    Meeting Abstract

    Sia, T. Y.; Moufarrij, S.; Zhou, Q.; Khurram, A.; Kemel, Y.; Iasonos, A.; Long Roche, K.; Stadler, Z. K.; Tew, W. P.; Lichtman, S. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: A phase 2 trial with biomarker analyses
    Journal Article

    Friedman, C. F.; Manning-Geist, B. L.; Zhou, Q.; Soumerai, T.; Holland, A.; Da Cruz Paula, A.; Green, H.; Ozsoy, M. A.; Iasonos, A.; Hollmann, T.; more...
    Nature Medicine (2024)

    Fulltext@MSK | Save
  • Carboplatin dosing in the treatment of ovarian cancer: An NRG Oncology group study
    Journal Article

    Praiss, A. M.; Miller, A.; Smith, J.; Lichtman, S. M.; Bookman, M.; Aghajanian, C.; Sabbatini, P.; Backes, F.; Cohn, D. E.; Argenta, P.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study
    Journal Article

    Rubinstein, M. M.; Doria, E. R.; Konner, J.; Lichtman, S.; Zhou, Q.; Iasonos, A.; Sarasohn, D.; Troso-Sandoval, T.; Friedman, C.; O'Cearbhaill, R.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • A phase II trial of IDO-inhibitor, BMS-986205 (IDO), and PD-1 inhibitor, nivolumab (NIVO), in recurrent or persistent endometrial cancer (EC; CA017-056)
    Meeting Abstract

    Kyi, C.; Rubinstein, M. M.; Shah, P.; Zhou, Q.; Iasonos, A.; Liu, Y.; Ramirez, L.; Paroder, V.; Green, A.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Dysfunctional CD8+T cells in the tumor microenvironment are associated with response to nivolumab in mismatch repair deficient (dMMR) or hypermutated ovarian (OVCA) or endometrial cancer (EC)
    Meeting Abstract

    Friedman, C. F.; Zhou, Q.; Iasonos, A.; Holland, A.; Ramirez, L.; Grisham, R. N.; Guo, R.; Lichtman, S. M.; Kyi, C.; Makker, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Risk factors for hospitalizations among older adults with gastrointestinal cancers
    Journal Article

    Li, D.; Sun, C. L.; Allen, R.; Crook, C. J.; Levi, A.; Ballena, R.; Klepin, H. D.; Elias, R.; Mohile, S. G.; Tew, W. P.; more...
    The Oncologist (2022)

    Fulltext@MSK | Save
  • Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer
    Journal Article

    Manning-Geist, B. L.; Gordhandas, S. B.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; O'Cearbhaill, R. E.; Zamarin, D.; Lichtman, S. M.; Sabbatini, P. J.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Secondary cytoreduction and carboplatin hyperthermic intraperitoneal chemotherapy for platinum-sensitive recurrent ovarian cancer: An MSK Team Ovary phase II study
    Journal Article

    Zivanovic, O.; Chi, D. S.; Zhou, Q.; Iasonos, A.; Konner, J. A.; Makker, V.; Grisham, R. N.; Brown, A. K.; Nerenstone, S.; Diaz, J. P.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • From assessment to implementation and beyond in cancer and aging research
    Review

    Lichtman, S. M.; Cohen, H. J.; Muss, H.; Tew, W. P.; Korc-Grodzicki, B.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save